- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01881139
Impact of Exercise Training on Cardiac Function in Man
June 17, 2013 updated by: No. 150 Central Hospital of the Chinese People Liberation Army
Effects of Exercise Training on Cardiac Function and Lipid Metabolism in Mem 18-22 Year Old
The purpose of this study is to monitor the impact of exercise training on cardiac functions and lipoprotein lipids.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Exercise can increase the mass of left ventricle, which is also called athletic heart.
Athletic heart is most frequently encountered as a pathological manifestation of cardiovascular disease, and the early determinants of athelitic remodeling in the general population are largely unknown.
We will recruit 45 men aged 18-25 years who will run 5000 meters 2/day for 3 months.
caridac function is examined by ECG and echocardiogram, blood pressure, lipoprotein, heart rate, body weight, cardiac troponin will be examined prior to exercise program and 3 months after exercise.
Study Type
Interventional
Enrollment (Actual)
46
Phase
- Early Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Henan
-
Luoyang, Henan, China, 471000
- No. 150 Central hospital of Chinese People's Liberation Army
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 22 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- men
- age 18-25 years
- body mass index (BMI) 18-25 kg/m2
- no regular exercise
- no tobacco use
- no current use of prescribed medications
- no self-report of acute of chronic diseases
Exclusion Criteria:
- conditions that do not meet the inclusion criteria listed.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: experimental 1
men with exercise training for 3 months
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
change of cardiac function at baseline to exercise training for 3 months
Time Frame: baseline to 3 months
|
baseline to 3 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
change of lipoprotein at baseline to exercise training for 3 months
Time Frame: baseline to 3 months
|
baseline to 3 months
|
|
change of heart rate at baseline to exercise training for 3 months
Time Frame: baseline to 3 months
|
baseline to 3 months
|
|
Change of body weight at baseline to exercise training for 3 months
Time Frame: baseline to 3 months
|
baseline to 3 months
|
|
change of cardiac troponin frome baseline to exercise training for 3 months
Time Frame: baselin to 3 months
|
baselin to 3 months
|
|
Change of blood pressure from baseline to exercise training for 3 months
Time Frame: baseline to 3 months
|
baseline to 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Shenxu Wang, MD, No. 150 Central Hospital of PLA
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2012
Primary Completion (Actual)
May 1, 2013
Study Completion (Actual)
May 1, 2013
Study Registration Dates
First Submitted
June 12, 2013
First Submitted That Met QC Criteria
June 17, 2013
First Posted (Estimate)
June 19, 2013
Study Record Updates
Last Update Posted (Estimate)
June 19, 2013
Last Update Submitted That Met QC Criteria
June 17, 2013
Last Verified
June 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 150CTSX002
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Disease
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruitingCardiovascular Disease (CVD) | Gender Incongruence | Cardiovascular (CV) Risk | Cardiovascular Health Status | Cardiovascular Disease Prevention | Cardiovascular Disease Acute | Cardiovascular Disease Risk FactorItaly
-
University of FloridaUniversity of Alabama at Birmingham; Brown UniversityCompletedCardiovascular Disease | Psychosocial Influence on Cardiovascular DiseaseUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedCardiovascular Disease | Inflammatory DiseaseUnited States
-
University College DublinBeacon Hospital, IrelandRecruitingCoronary Artery Disease (CAD) | Cardiovascular Diseases (CVD) | Cardiovascular Disease Prevention | Cardiovascular Disease Risk FactorIreland
-
Fu Jen Catholic UniversityRecruitingCardiovascular Disease | Cardiovascular SurgeryTaiwan
-
Beijing Anzhen HospitalRecruiting
-
Baptist Health South FloridaUniversity of California, Los Angeles; Quest Diagnostics-Nichols InsituteActive, not recruitingCardiovascular DiseaseUnited States
-
Laval UniversityActive, not recruitingCardiovascular DiseaseCanada
-
Institut National de Recherche pour l'Agriculture...Completed
-
Institut National de Recherche pour l'Agriculture...Completed
Clinical Trials on exercise training
-
University of British ColumbiaMichael Smith Foundation for Health ResearchCompleted
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloCompleted
-
Universidade Norte do ParanáCompleted
-
Universita di VeronaRecruiting
-
University of Colorado, DenverVA Eastern Colorado Health Care SystemCompletedHealthy | Overweight | Type 2 Diabetes Mellitus | Cardiovascular Risk FactorUnited States
-
National Taiwan University HospitalCompletedAtrial FibrillationTaiwan
-
Hacettepe UniversityCompleted
-
Toronto Rehabilitation InstituteCompletedAcute Myeloid LeukemiaCanada
-
University of LeipzigCompletedImpact of Intensive Exercise Training on Coronary Collateral Circulation in Patients With Stable CADStable Coronary Artery DiseaseGermany
-
Helse Stavanger HFStavanger Health ResearchCompletedVentricular TachycardiaNorway